silybin has been researched along with Dermatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, Z; Li, Y; Liu, W; Zhang, K; Zheng, X | 1 |
| Agarwal, R; Singh, RP | 1 |
1 review(s) available for silybin and Dermatitis
| Article | Year |
|---|---|
Mechanisms and preclinical efficacy of silibinin in preventing skin cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cell Communication; Cell Cycle; Cell Proliferation; Dermatitis; DNA Damage; Humans; Mice; Mitogens; Silybin; Silymarin; Skin Neoplasms; Tumor Suppressor Protein p53; Ultraviolet Rays | 2005 |
1 other study(ies) available for silybin and Dermatitis
| Article | Year |
|---|---|
Potent inhibitory effect of silibinin from milk thistle on skin inflammation stimuli by 12-O-tetradecanoylphorbol-13-acetate.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cyclooxygenase 2; Dermatitis; Dose-Response Relationship, Drug; Female; Inflammation; Interleukin-1beta; Interleukin-6; Mice; Mice, Inbred BALB C; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Silybin; Silybum marianum; Silymarin; Skin; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2015 |